CARLSBAD, Calif., Jan. 19, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that Mark Francois has been named the Company's Senior Director of Investor Relations.
Mr. Francois will be responsible for providing overall strategic direction and leadership to Alphatec Spine's global investor relations program to effectively communicate the Company's value proposition to the investment community.
Since 2002, Mr. Francois held the position of Director of Investor Relations for DJO Global, Inc., a medical device company with nearly $1 billion in annual sales, where he was responsible for daily interaction with investors and shareholders, marketing the company to institutional investors, as well as making introductions to industry analysts and the media. Prior to DJO Global, Mr. Francois held senior investor relations positions at several San Diego-based companies including Wireless Facilities, Inc., Safeskin Corporation and Quidel Corporation.
"We are pleased to have Mark join the Alphatec Spine team to lead our strategic investor relations function," said Dirk Kuyper, the Company's President and CEO. "Mark is a seasoned professional in the medical device industry with nearly 30 years experience, the last 20 of which in an investor relations capacity. As a leading innovator of products for the surgical treatment of spine disorders, the heart of Alphatec's business is improving the quality of life of people suffering from the debilitating effects of chronic back and neck pain; and in turn helping patients regain their active lifestyles.We look forward to Mark's strategy designed to increase the visibility of Alphatec in the capital markets so that existing and prospective shareholders will better appreciate the Company's underlying value. I also want to thank Westwicke Partners for their strategic guidance and excellent IR counsel the past few years. We appreciate their dedication and professionalism and wish them well after a brief transition period."
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company's mission is to combine world-class customer service with innovative, surgeon-driven design that helps improve the aging patient's quality of life. To achieve its goals, the Company is focused on new solutions for patients with osteoporosis, stenosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its U.S. operations, the Company also markets its products in over 50 international markets through its affiliate, Scient'x S.A.S., via a direct sales force in France, Italy and the United Kingdom and via independent distributors in the rest of Europe, the Middle East and Africa, South America and Latin America. In Asia and Australia, the Company markets its products through its subsidiary, Alphatec Pacific, Inc., and through Scient'x's distributors in China, Korea and Australia.
The Alphatec Holdings, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3520